Page 128 - 南京医科大学自然版

第45卷第3期
·416 · 南 京 医 科 大 学 学 报 2025年3月

cule alpha ⁃ synuclein misfolding inhibitor，NPT200 ⁃ 11， sis［J］. Sci Rep，2017，7（1）：9968
produces multiple benefits in an animal model of Parkin⁃ ［53］XU Y，ZHANG Y Y，QUAN Z Z，et al. Epigallocatechin
son’s disease［J］. Sci Rep，2018，8（1）：16165 gallate（EGCG）inhibits alpha ⁃ synuclein aggregation：a
［41］ JING X N，SHI Q Y，BI W，et al. Rifampicin protects potential agent for Parkinson’s disease［J］. Neurochem
PC12 cells from rotenone⁃induced cytotoxicity by activat⁃ Res，2016，41（10）：2788-2796
ing GRP78 via PERK ⁃ eIF2α ⁃ ATF4 pathway［J］. PLoS ［54］ INDEN M，TAKAGI A，KITAI H，et al. Kaempferol has
One，2014，9（3）：e92110 potent protective and antifibrillogenic effects for α⁃synu⁃
［42］LIANG Y R，ZHENG D Z，PENG S D，et al. Rifampicin clein neurotoxicity in vitro［J］. Int J Mol Sci，2021，22
attenuates rotenone ⁃ treated microglia inflammation via （21）：11484
improving lysosomal function［J］. Toxicol In Vitro，2020， ［55］SUN C P，ZHOU J J，YU Z L，et al. Kurarinone alleviated
63：104690 Parkinson’s disease via stabilization of epoxyeicosatrienoic
［43］WU X，LIANG Y R，JING X N，et al. Rifampicin prevents acids in animal model［J］. Proc Natl Acad Sci USA，
SH⁃SY5Y cells from rotenone⁃induced apoptosis via the 2022，119（9）：e2118818119
PI3K/Akt/GSK ⁃ 3β/CREB signaling pathway［J］. Neuro⁃ ［56］DEUS C M，PEREIRA S P，CUNHA⁃OLIVEIRA T，et al.
chem Res，2018，43（4）：886-893 A mitochondria ⁃ targeted caffeic acid derivative reverts
［44］ STOILOVA T，COLOMBO L，FORLONI G，et al. A new cellular and mitochondrial defects in human skin fibroblasts
face for old antibiotics：tetracyclines in treatment of amy⁃ from male sporadic Parkinson’s disease patients［J］. Redox
loidoses［J］. J Med Chem，2013，56（15）：5987-6006 Biol，2021，45：102037
［45］MERLINI G，ASCARI E，AMBOLDI N，et al. Interaction ［57］SINGH L. Daidzein’s potential in halting neurodegenera⁃
of the anthracycline 4’⁃iodo⁃ 4’⁃deoxydoxorubicin with tion：unveiling mechanistic insights［J/OL］. Naunyn Schmie⁃
amyloid fibrils：inhibition of amyloidogenesis［J］. Proc debergs Arch Pharmacol，2024，DOI：10.1007/s00210 ⁃
Natl Acad Sci U S A，1995，92（7）：2959-2963 024⁃03356⁃5
［46］ LI H T，LIN D H，LUO X Y，et al. Inhibition of alpha⁃ ［58］ SHAY J，ELBAZ H A，LEE I，et al. Molecular mecha⁃
synuclein fibrillization by dopamine analogs via reaction nisms and therapeutic effects of（⁃）⁃epicatechin and other
with the amino groups of alpha⁃synuclein. Implication for polyphenols in cancer，inflammation，diabetes，and neuro⁃
dopaminergic neurodegeneration［J］. FEBS J，2005，272 degeneration［J］. Oxid Med Cell Longev，2015，2015：
（14）：3661-3672 181260
［47］LATAWIEC D，HERRERA F，BEK A，et al. Modulation ［59］ ZHAI Y M，WANG T Y，FU Y M，et al. Ferulic acid：a
of alpha⁃synuclein aggregation by dopamine analogs［J］. review of pharmacology，toxicology，and therapeutic effects
PLoS One，2010，5（2）：e9234 on pulmonary diseases［J］. Int J Mol Sci，2023，24（9）：
［48］XU B K，CHEN J，LIU Y H. Curcumin interacts with α⁃ 8011
synuclein condensates to inhibit amyloid aggregation un⁃ ［60］ GÜZELAD Ö，ÖZKAN A，PARLAK H，et al. Protective
der phase separation［J］. ACS Omega，2022，7（34）： mechanism of syringic acid in an experimental model of
30281-30290 Parkinson’s disease［J］. Metab Brain Dis，2021，36（5）：
［49］ AHMAD B，LAPIDUS L J. Curcumin prevents aggrega⁃ 1003-1014
tion in α⁃synuclein by increasing reconfiguration rate［J］. ［61］DA SILVA F L，COELHO CERQUEIRA E，DE FREITAS
J Biol Chem，2012，287（12）：9193-9199 M S，et al. Vitamins K interact with N⁃terminus α⁃synu⁃
［50］AHSAN N，MISHRA S，JAIN M K，et al. Curcumin pyr⁃ clein and modulate the protein fibrillization in vitro.
azole and its derivative n ⁃（3 ⁃ nitrophenylpyrazole）cur⁃ Exploring the interaction between quinones and α⁃synu⁃
cumin inhibit aggregation，disrupt fibrils and modulate clein［J］. Neurochem Int，2013，62（1）：103-112
toxicity of wild type and mutant α⁃synuclein［J］. Sci Rep， ［62］JING X，WEI X B，REN M R，et al. Neuroprotective
2015，5：9862 effects of tanshinoneⅠagainst 6⁃OHDA⁃induced oxida⁃
［51］GRELLE G，OTTO A，LORENZ M，et al. Black tea theafla⁃ tive stress in cellular and mouse model of Parkinson’s
vins inhibit formation of toxic amyloid⁃β and α⁃synuclein disease through upregulating Nrf2［J］. Neurochem Res，
fibrils［J］. Biochemistry，2011，50（49）：10624-10636 2016，41（4）：779-786
［52］ZHANG X，DU L D，ZHANG W，et al. Therapeutic effects ［63］SUBEDI L，GAIRE B P. TanshinoneⅡA：a phytochemical
of baicalein on rotenone ⁃ induced Parkinson’s disease as a promising drug candidate for neurodegenerative
through protecting mitochondrial function and biogene⁃ diseases［J］. Pharmacol Res，2021，169：105661